Home › Relapsing-Remitting Multiple Sclerosis › Illinois › Chicago
Relapsing-Remitting Multiple Sclerosis clinical trials in Chicago, IL
5 studies for Relapsing-Remitting Multiple Sclerosis are looking for participants at sites in and around Chicago (within about 30 miles). Open a study to see who can join and how to contact the study team.
Study to Evaluate the Effectiveness and Safety of Ozanimod Compared to Fingolimod in Children and Adolescents With Relapsing Remitting Multiple Sclerosis
RecruitingPhase 3
- University of Chicago Medical Center, Chicago
Intermittent Hypoxia in Persons With Multiple Sclerosis
Recruiting
- Shirley Ryan AbilityLab, Chicago
Ublituximab (Briumvi) for Early Forms of Relapsing Multiple Sclerosis
RecruitingPhase 4
- Northwestern Memorial Hospital, Chicago
Effects of Acute Intermittent Hypoxia on Neuroplasticity in MS
Recruiting
- Shirley Ryan AbilityLab, Chicago
Home Based Functional Balance Intervention for Multiple Sclerosis
Recruiting
- University of Illinois at Chicago, Chicago
Relapsing-Remitting Multiple Sclerosis trials in other cities
Other studies in Chicago
- Non-Small Cell Lung Cancer62 studies
- Breast Cancer58 studies
- Cancer (all types)53 studies
- Metastatic Cancer45 studies
- Prostate Cancer45 studies
- Obesity42 studies
- Lung Cancer41 studies
- Ovarian Cancer36 studies
- Stroke35 studies
- Heart Failure32 studies
- Colorectal Cancer32 studies
- Overweight28 studies
From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.